Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.

Shah M, Dowdy D, Joloba M, Ssengooba W, Manabe YC, Ellner J, Dorman SE.

AIDS. 2013 Nov 28;27(18):2883-92. doi: 10.1097/QAD.0000000000000008.

PMID:
25119690
[PubMed - in process]
Free PMC Article
2.

Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting.

Lusiba JK, Nakiyingi L, Kirenga BJ, Kiragga A, Lukande R, Nsereko M, Ssengooba W, Katamba A, Worodria W, Joloba ML, Mayanja-Kizza H.

PLoS One. 2014 Jul 22;9(7):e102702. doi: 10.1371/journal.pone.0102702. eCollection 2014.

PMID:
25051491
[PubMed - in process]
Free PMC Article
3.

Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda.

Manabe YC, Nonyane BA, Nakiyingi L, Mbabazi O, Lubega G, Shah M, Moulton LH, Joloba M, Ellner J, Dorman SE.

PLoS One. 2014 Jul 7;9(7):e101459. doi: 10.1371/journal.pone.0101459. eCollection 2014.

PMID:
25000489
[PubMed - in process]
Free PMC Article
4.

Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda.

Ma N, Zalwango S, Malone LL, Nsereko M, Wampande EM, Thiel BA, Okware B, Igo RP Jr, Joloba ML, Mupere E, Mayanja-Kizza H, Boom WH, Stein CM; Tuberculosis Research Unit (TBRU).

BMC Infect Dis. 2014 Jun 27;14:352. doi: 10.1186/1471-2334-14-352.

PMID:
24970328
[PubMed - in process]
Free PMC Article
5.

Antibacterial activities of extracts from Ugandan medicinal plants used for oral care.

Ocheng F, Bwanga F, Joloba M, Borg-Karlson AK, Gustafsson A, Obua C.

J Ethnopharmacol. 2014 Aug 8;155(1):852-5. doi: 10.1016/j.jep.2014.06.027. Epub 2014 Jun 16.

PMID:
24945400
[PubMed - in process]
6.

Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.

Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P.

Lancet Infect Dis. 2014 Jul;14(7):563-71. doi: 10.1016/S1473-3099(14)70733-9. Epub 2014 May 5. Erratum in: Lancet Infect Dis. 2014 Jul;14(7):548.

PMID:
24810491
[PubMed - in process]
7.

Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis.

Jones-López E, Manabe YC, Palaci M, Kayiza C, Armstrong D, Nakiyingi L, Ssengooba W, Gaeddert M, Kubiak R, Almeida Júnior P, Alland D, Dietze R, Joloba M, Ellner JJ, Dorman SE.

J Clin Microbiol. 2014 Jul;52(7):2513-20. doi: 10.1128/JCM.00642-14. Epub 2014 May 7.

PMID:
24808236
[PubMed - in process]
8.

CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda.

Nakanjako D, Otiti-Sengeri J, Ssewanyana I, Nabatanzi R, Bayigga L, Kirimunda S, Joloba M, Manabe YC, Kambugu A, Colebunders R, Mayanja-Kizza H.

Immunol Lett. 2014 Sep;161(1):44-9. doi: 10.1016/j.imlet.2014.04.011. Epub 2014 Apr 28.

PMID:
24785834
[PubMed - in process]
9.

The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.

Lukoye D, Katabazi FA, Musisi K, Kateete DP, Asiimwe BB, Okee M, Joloba ML, Cobelens FG.

Antimicrob Agents Chemother. 2014 Jul;58(7):3853-9. doi: 10.1128/AAC.02338-13. Epub 2014 Apr 28.

PMID:
24777100
[PubMed - in process]
10.

What is the most reliable solid culture medium for tuberculosis treatment trials?

Joloba ML, Johnson JL, Feng PJ, Bozeman L, Goldberg SV, Morgan K, Gitta P, Boom HW, Heilig CM, Mayanja-Kizza H, Eisenach KD.

Tuberculosis (Edinb). 2014 May;94(3):311-6. doi: 10.1016/j.tube.2014.03.002. Epub 2014 Mar 19.

PMID:
24698569
[PubMed - in process]
11.

Clinico-pathological features of tuberculosis due to Mycobacterium tuberculosis Uganda genotype in patients with tuberculous lymphadenitis: a cross sectional study.

Wamala D, Asiimwe B, Kigozi E, Mboowa G, Joloba M, Kallenius G.

BMC Clin Pathol. 2014 Apr 2;14(1):14. doi: 10.1186/1472-6890-14-14.

PMID:
24690344
[PubMed]
Free PMC Article
12.

Diagnostic Accuracy of a Rapid Urine Lipoarabinomannan Test for Tuberculosis in HIV-Infected Adults.

Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, Sikhondze W, Mbabazi O, Nonyane BA, Shah M, Joloba ML, Alland D, Ellner JJ, Dorman SE.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):270-9. doi: 10.1097/QAI.0000000000000151.

PMID:
24675585
[PubMed - in process]
13.

How we determined the most reliable solid medium for studying treatment of tuberculosis.

Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV.

Tuberculosis (Edinb). 2014 May;94(3):317-22. doi: 10.1016/j.tube.2014.02.006. Epub 2014 Mar 4.

PMID:
24661816
[PubMed - in process]
14.

Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.

Shah M, Ssengooba W, Armstrong D, Nakiyingi L, Holshouser M, Ellner JJ, Joloba M, Manabe YC, Dorman SE.

AIDS. 2014 Jun 1;28(9):1307-14. doi: 10.1097/QAD.0000000000000264.

PMID:
24637544
[PubMed - in process]
Free PMC Article
15.

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.

Kirenga BJ, Levin J, Ayakaka I, Worodria W, Reilly N, Mumbowa F, Nabanjja H, Nyakoojo G, Fennelly K, Nakubulwa S, Joloba M, Okwera A, Eisenach KD, McNerney R, Elliott AM, Mugerwa RD, Smith PG, Ellner JJ, Jones-López EC.

PLoS One. 2014 Mar 7;9(3):e90614. doi: 10.1371/journal.pone.0090614. eCollection 2014.

PMID:
24608875
[PubMed - in process]
Free PMC Article
16.

A metabolic biosignature of early response to anti-tuberculosis treatment.

Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT.

BMC Infect Dis. 2014 Jan 31;14:53. doi: 10.1186/1471-2334-14-53.

PMID:
24484441
[PubMed - in process]
Free PMC Article
17.

High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.

Bayigga L, Nabatanzi R, Sekiziyivu PN, Mayanja-Kizza H, Kamya MR, Kambugu A, Olobo J, Kiragga A, Kirimunda S, Joloba M, Nakanjako D.

BMC Immunol. 2014 Jan 31;15:2. doi: 10.1186/1471-2172-15-2.

PMID:
24483185
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda.

Tukwasibwe S, Mugenyi L, Mbogo GW, Nankoberanyi S, Maiteki-Sebuguzi C, Joloba ML, Nsobya SL, Staedke SG, Rosenthal PJ.

J Infect Dis. 2014 Jul 1;210(1):154-7. Epub 2014 Jan 19.

PMID:
24446524
[PubMed - in process]
19.

Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda.

Wekesa C, Kirenga BJ, Joloba ML, Bwanga F, Katamba A, Kamya MR.

Int J Tuberc Lung Dis. 2014 Feb;18(2):216-9. doi: 10.5588/ijtld.13.0464.

PMID:
24429316
[PubMed - in process]
20.

Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing.

Clark TG, Mallard K, Coll F, Preston M, Assefa S, Harris D, Ogwang S, Mumbowa F, Kirenga B, O'Sullivan DM, Okwera A, Eisenach KD, Joloba M, Bentley SD, Ellner JJ, Parkhill J, Jones-López EC, McNerney R.

PLoS One. 2013 Dec 11;8(12):e83012. doi: 10.1371/journal.pone.0083012. eCollection 2013.

PMID:
24349420
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk